Complementarity of blue dye and isotope in sentinel node localization for breast cancer: Univariate and multivariate analysis of 966 procedures

Annals of Surgical Oncology

Volumn 8, Issue 1, 2001, Pages 13-19

  Cody, H S ^a   Fey, J ^a   Akhurst, T ^a   Fazzari, M ^a   Mazumdar, M ^a   Yeung, H ^a   Yeh, S D J ^a   Borgen, P I ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer surgery; Lymphoscintigraphy; Sentinel node biopsy

Indexed keywords

BLUE DYE; DYE; RADIOISOTOPE; TECHNETIUM SULFUR COLLOID TC 99M; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CENTER; CANCER INVASION; CANCER STAGING; HUMAN; HUMAN TISSUE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE; TUMOR LOCALIZATION;

BREAST NEOPLASMS; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; INJECTIONS, SUBCUTANEOUS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0035150874     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.1.13     Document Type: Article

References (40)

1. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
2. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
3. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer
4. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer
5. Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients?
6. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
7. Development of sentinel node targeting technique in breast cancer patients
8. Minimally invasive breast cancer staging using lymphatic mapping with radiolabeled dextran
9. The sentinel node in breast cancer - A multicenter validation study
10. Gamma-probe-guided resection of the sentinel lymph node in breast cancer
11. Sentinel lymph node biopsy for staging breast cancer
12. Sentinel node biopsy in the staging of breast cancer
13. Sentinel lymphadenectomy for breast cancer: Experience with 180 consecutive patients: Efficacy of filtered technetium 99m sulphur colloid with overnight migration time
14. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy
15. Unfiltered sulfur colloid and sentinel node biopsy for breast cancer: Technical and kinetic considerations
16. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series
17. Sentinel lymph node biopsy for breast cancer: The role of previous biopsy on patient eligibility
18. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
19. Sentinel lymphadenectomy in breast cancer
20. Sentinel lymphadenectomy for breast cancer in a community managed care setting
21. Sentinel node localization in patients with breast cancer
22. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye
23. Initial experience in a community hospital with sentinel lymph node mapping and biopsy for evaluation of axillary lymph node status in palpable invasive breast cancer
24. Learning sentinel node biopsy: Results of a prospective randomized trial of two techniques
25. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
26. Intradermal blue dye to identify sentinel lymph node in breast cancer
27. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center
28. Sentinel node biopsy in breast cancer
29. The role of sentinel lymph node biopsy in breast cancer
30. Routine preoperative lymphoscintigraphy is not necessary prior to sentinel node biopsy for breast cancer
31. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer
32. The feasibility and accuracy of sentinel lymph node biopsy for breast carcinoma
33. Lessons learned from 500 cases of lymphatic mapping for breast cancer
34. Sentinel lymph node biopsy in breast cancer: Unfiltered radioisotope is superior to filtered
35. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients
36. Credentialing for breast lymphatic mapping - How many cases are enough?
37. Biopsy method and excision volume do not effect success rate of subsequent sentinel lymph node dissection in breast cancer
38. Location of sentinel lymph nodes in patients with cutaneous melanoma: New insights into lymphatic anatomy
39. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer
40. Intradermal isotope injection: A highly accurate method of lymphatic mapping in breast carcinoma